CompletedNot Applicable

Study to Assess the Reliability of PASI Scoring Using Digital-Based Images

Canada34 participantsStarted 2023-06-02

Plain-language summary

This is an open-labeled study to evaluate the reliability of digital photographs for the remote assessment of the disease severity of plaque psoriasis.

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Male and female subjects aged 18 to 75 years, inclusive, at the time of consent.
✓. Subject has at least a 6-month history of plaque psoriasis prior to screening visit (information obtained from medical chart or subject's physician, or directly from the subject).
✓. Subject has plaque psoriasis covering at least 0.5% his/her total BSA at screening/Day 1 visit.
✓. Subject has a PGA score ≥2 at screening/Day 1 visit.

What they're measuring

Intraclass Correlation Coefficient (ICC) between Psoriasis Area and Severity Index (PASI) assessed in-person and using digital photographs, all cohorts combined.

Timeframe: Day 1

Trial details

NCT IDNCT05835843

SponsorInnovaderm Research Inc.

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-07-09

View on ClinicalTrials.gov More Plaque Psoriasis trials